Oric Pharmaceuticals Inc. (ORIC): Price and Financial Metrics
ORIC Price/Volume Stats
| Current price | $9.58 | 52-week high | $16.65 |
| Prev. close | $10.04 | 52-week low | $6.33 |
| Day low | $9.57 | Volume | 301,500 |
| Day high | $10.20 | Avg. volume | 788,182 |
| 50-day MA | $9.11 | Dividend yield | N/A |
| 200-day MA | $9.29 | Market Cap | 676.03M |
ORIC Stock Price Chart Interactive Chart >
Oric Pharmaceuticals Inc. (ORIC) Company Bio
Oric Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
ORIC Price Returns
| 1-mo | 16.69% |
| 3-mo | 8.62% |
| 6-mo | -14.77% |
| 1-year | -8.85% |
| 3-year | -12.35% |
| 5-year | N/A |
| YTD | 18.71% |
| 2024 | -12.28% |
| 2023 | 56.20% |
| 2022 | -59.93% |
| 2021 | -56.57% |
| 2020 | N/A |
Loading social stream, please wait...